Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Prostate Cancer Clinical Trials in Arizona | 375 Studies

Clinical Trials Prostate CancerArizona

Prostate Cancer Clinical Trials in Arizona

Find 375 clinical trials for prostate cancer near Arizona. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 375 trials

CompletedA Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how participants with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency…NCT02975934·Birmingham, Alabama and 149 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Androgens can stimulate the growth of prostate cancer cells.NCT00028769·Mobile, Alabama and 90 others

CompletedS9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy and hormone therapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004001·Scottsdale, Arizona and 15 others

CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersThis is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in…NCT03454451·Tucson, Arizona and 26 others

RecruitingStereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE TrialThis phase II trial studies the effects of stereotactic body radiation therapy (SBRT) and the timing of treatment with androgen receptor pathway inhibitor (ARPI) plus androgen…NCT06378866·Phoenix, Arizona and 2 others

Active not recruitingStudy of Hypo-fractionated Proton Radiation for Low Risk Prostate CancerThe purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 treatments over 8½-9…NCT01230866·Phoenix, Arizona and 4 others

CompletedA Study of Leuprolide to Treat Prostate CancerTo assess the efficacy and safety of 2 new formulations of leuprolide acetate 45 mg 6-month depot, Formulation A or Formulation B, for the treatment of patients with prostate…NCT00626431·Birmingham, Alabama and 62 others

CompletedS0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyRATIONALE: Drugs used in chemotherapy, such as docetaxel, prednisone, and atrasentan work in different ways to stop the growth of tumor cells, either by killing the cells or by…NCT00134056·Mobile, Alabama and 553 others

RecruitingA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of…NCT07225946·Chandler, Arizona and 157 others

Active not recruitingStudy of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participants with metastatic castration resistant prostate cancer…NCT05348577·Yuma, Arizona and 216 others

CompletedA Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)The purpose of this study is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate…NCT02985957·Tucson, Arizona and 58 others

CompletedStudy of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With DocetaxelThis is a Phase II, non-randomized, open label study of ILX651 in patients with hormone-refractory prostate cancer previously treated with docetaxel.NCT00082134·Tucson, Arizona and 11 others

CompletedNanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsThis pilot trial studies how well nanoparticle albumin-bound rapamycin works in treating patients with cancer that as has spread to other places in the body and usually cannot be…NCT02646319·Scottsdale, Arizona and 1 other

TerminatedTo Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate CancerTo determine an effective dose of VERU-100 for the treatment of advanced prostate cancer by assessing its effect on testosterone levels by Day 28 and maintenance through Day 91.NCT04843319·Tucson, Arizona and 10 others

Active not recruitingA Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)The purpose of this study is to learn whether adding abemaciclib to abiraterone plus prednisone prolongs the time before prostate cancer gets worse.NCT05288166·Prescott, Arizona and 265 others

CompletedPhase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer PatientsThis is a multi-center, first-in-human, open-label, Phase 1/2A dose-escalation study in which eligible patients with metastatic castration-resistant prostate carcinoma (mCRPC)…NCT02987829·Birmingham, Alabama and 4 others

RecruitingA Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate CancerThis is a Phase 1 and Phase 2 study to evaluate the safety and antitumor activity of INV-9956 in adult patients with advanced metastatic Castration Resistant Prostate Cancer.NCT06609005·Scottsdale, Arizona and 21 others

CompletedPositioning and Tracking the Prostate During External Beam RadiationThe purpose of this study is to evaluate a non-ionizing electromagnetic method to align the prostate treatment site for radiation therapy and to monitor its position throughout…NCT00123838·Scottsdale, Arizona and 4 others

Active not recruitingAn Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASThe purpose of this study is to determine if apalutamide plus gonadotropin releasing hormone (GnRH) agonist in participants with high-risk, localized or locally advanced prostate…NCT02531516·Homewood, Alabama and 262 others

CompletedA Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate CancerThe purpose of this international, phase 2, open-label, response rate study of talazoparib is to assess the efficacy and safety of talazoparib in men with DNA repair defects…NCT03148795·Tempe, Arizona and 119 others

PreviousPage 14 of 19Next

Other Conditions in Arizona

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma